Ayala Pharmaceuticals Margen de beneficio
¿Qué es el Margen de beneficio de Ayala Pharmaceuticals?
El Margen de beneficio de Ayala Pharmaceuticals Inc. es -2,316.60%
¿Cuál es la definición de Margen de beneficio?
El margen de ganancia es una medida de la rentabilidad. La misma se calcula al encontrar la ganancia neta como un porcentaje de los ingresos.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Margen de beneficio de compañías en Sector Health Care en NASDAQ en comparadas con Ayala Pharmaceuticals
¿Qué hace Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas con margen de beneficio similar a Ayala Pharmaceuticals
- Silver Mines tiene Margen de beneficio de -2,389.53%
- Protean tiene Margen de beneficio de -2,385.00%
- Redbank Copper tiene Margen de beneficio de -2,375.00%
- Cobalt Blue tiene Margen de beneficio de -2,347.64%
- Stanrose Mafatlal Investments and Finance tiene Margen de beneficio de -2,340.24%
- 4Dx tiene Margen de beneficio de -2,332.63%
- Ayala Pharmaceuticals tiene Margen de beneficio de -2,316.60%
- HTC Purenergy tiene Margen de beneficio de -2,315.07%
- Delcath Systems tiene Margen de beneficio de -2,314.56%
- Delcath Systems tiene Margen de beneficio de -2,308.86%
- Theranexus SA tiene Margen de beneficio de -2,307.43%
- Infinity Lithium tiene Margen de beneficio de -2,296.51%
- Vitalibis tiene Margen de beneficio de -2,283.33%